drugset / Trial / NCT05993897
Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling
RandomizedParallel-groupTriple-blindPrevention
Summary
Investigators are going to assess direct effect of SGLT2 inhibitors on left atrial remodeling in participants with nonvalvular paroxysmal atrial fibrillation regardless of diabetes status.
Timeline
- Start
- 2024-08-20
- Primary completion
- 2025-06-30
- Completion
- 2025-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dapagliflozin | Small molecule | 10 mg | Oral |
| Comparator | Amiodarone | Small molecule | 200 mg | Intravenous |
| Comparator | Rivaroxaban | Other / unclassified | 20 mg | Oral |
| Comparator | propafenone | Unknown | 150 mg | Oral |